Sepsis-dose hydroxocobalamin as rescue therapy for catecholamine-resistant pediatric septic shock: A case report and literature review
Authors:
- Amir SaeedASAmir Saeed
- Morteza AzariMAMorteza Azari
- Seyed Reza Abdipour MehrianSMSeyed Reza Abdipour Mehrian
- Elahe MeftahEMElahe Meftah
- Ali AmanatiAAAli Amanati
Open Access
- 12 June 2026
- journal article
- Published by Elsevier in Medical Reports
- Vol. 18
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Treatment of refractory shock with vitamin B12: A narrative reviewNutrition in Clinical Practice, 2023
- Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial)Journal of Critical Care, 2023
- High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic ShockChest, 2022
- Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shockJournal of Critical Care, 2022
- Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in childrenIntensive Care Medicine, 2020
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease StudyThe Lancet, 2020
- High‐Dose Vitamin B12 in Vasodilatory Shock: A Narrative ReviewNutrition in Clinical Practice, 2019
- Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case seriesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2017
- Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic ShockChest, 2017
- Extravascular lung water index and global end-diastolic volume index should be corrected in childrenJournal of Critical Care, 2011